Terms ending in 2028
Every in-force patent on Agena Bioscience, Inc.'s record whose computed term ends in 2028, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 7,888,127 | Methods for Reducing Adduct Formation for Mass Spectrometry Analysis In force · High confidence | Agena Bioscience, Inc. | In force | High confidence | |
| US 9,873,912 | Compositions and Processes for Improved Mass Spectrometry Analysis In force · High confidence | Agena Bioscience, Inc. | In force | High confidence | |
| US 10,329,612 | Compositions and Processes for Improved Mass Spectrometry Analysis In force · High confidence | Agena Bioscience, Inc. | In force | High confidence | |
| US 12,077,819 | Compositions and Processes for Improved Mass Spectrometry Analysis In force · High confidence | Agena Bioscience, Inc. | In force | High confidence | |
| US 9,068,953 | Integrated Robotic Sample Transfer Device In force · Medium confidence | Agena Bioscience, Inc. | In force | Medium confidence |
5 of 5 patents shown. Soonest term end first, then patent number.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.